A phase I–II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors
Schöffski, P., Reichardt, P., Blay, J.-Y., Dumez, H., Morgan, J.A., Ray-Coquard, I., Hollaender, N., Jappe, A., Demetri, G.D.
Published in Annals of oncology (01.10.2010)
Published in Annals of oncology (01.10.2010)
Get full text
Journal Article
Correcting Overall Survival for the Impact of Crossover Via a Rank-Preserving Structural Failure Time (RPSFT) Model in the RECORD-1 Trial of Everolimus in Metastatic Renal-Cell Carcinoma
Korhonen, P., Zuber, E., Branson, M., Hollaender, N., Yateman, N., Katiskalahti, T., Lebwohl, D., Haas, T.
Published in Journal of biopharmaceutical statistics (01.11.2012)
Published in Journal of biopharmaceutical statistics (01.11.2012)
Get full text
Journal Article
7127 Results from additional analyses of patient reported outcomes in RECORD-1 – a randomized trial of everolimus with metastatic renal cell carcinoma patients
Beaumont, J, Cella, D, Hollaender, N, Zheng, J, Baladi, J.F, Hutson, T
Published in European journal of cancer supplements (2009)
Published in European journal of cancer supplements (2009)
Get full text
Journal Article
Phase I study of paclitaxel administered as a 1-hour infusion: toxicity and pharmacokinetics
Maier-Lenz, H, Hauns, B, Haering, B, Koetting, J, Mross, K, Unger, C, Bauknecht, T, du Bois, A, Meerpohl, H G, Hollaender, N, Diergarten, K
Published in Seminars in oncology (01.12.1997)
Get more information
Published in Seminars in oncology (01.12.1997)
Journal Article
728 DYNAMIC TUMOR MODELLING OF THE RECORD-1 PHASE II TRIAL OF EVEROLIMUS QUANTIFIES RELATIONSHIP BETWEEN DOSE AND TUMOR GROWTH IN METASTATIC RENAL CELL CARCINOMA
Stein, A, Wang, W, Carter, A, Chiparus, O, Hollaender, N, Motzer, R, Sarr, C
Published in European urology supplements : official journal of the European Association of Urology (2011)
Published in European urology supplements : official journal of the European Association of Urology (2011)
Get full text
Journal Article
Quantifying the effect of everolimus on both tumor growth and new metastases in metastatic renal cell carcinoma (RCC): A dynamic tumor model of the RECORD-1 phase III trial
Stein, A. M., Carter, A., Hollaender, N., Motzer, R. J., Sarr, C.
Published in Journal of clinical oncology (20.05.2011)
Published in Journal of clinical oncology (20.05.2011)
Get full text
Journal Article
Correcting overall survival (OS) effect for the impact of cross-over via rank preserving structural failure time (RPSFT) model: Case of mRCC RECORD-1 trial of everolimus (EVE)
Zuber, E., Korhonen, P., Branson, M., Hollaender, N., Katiskalahti, T., Lebwohl, D. E., Haas, T.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
Everolimus with bevacizumab versus interferon alfa-2a plus bevacizumab as first-line therapy in patients with metastatic clear cell renal cell carcinoma
Ravaud, A., Bajetta, E., Kay, A. C., Pelov, D., Hollaender, N., Rouyrre, N., Thompson, J. A.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
First-line everolimus followed by second-line sunitinib versus the opposite treatment sequence in patients with metastatic renal cell carcinoma (mRCC)
Knox, J. J., Kay, A. C., Schiff, E., Hollaender, N., Rouyrre, N., Ravaud, A., Motzer, R. J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A one-sample progression-free survival (PFS) hazard ratio estimate for planning a randomized phase II study (RP2) in mRCC utilizing evidence from RECORD-1
Kovalchik, S. A., Mietlowski, W., Kay, A. C., Hollaender, N., Kpamegan, E., Wang, Y., Dugan, M. H.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
A proof-of-concept (PoC) phase II criterion in a noninferiority context with application in patients with metastatic renal cell carcinoma (mRCC)
Hollaender, N., Rouyrre, N., Neuenschwander, B., Branson, M., Haas, T., Schiff, E., Kay, A. C., Lebwohl, D. E., Zuber, E.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
An indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory mRCC patients
Casciano, R., Malangone, E., Sherman, S., Baladi, J., Kay, A. C., Kim, D., Garay, C. A., Hollaender, N., Wang, J.
Published in Journal of clinical oncology (20.05.2010)
Published in Journal of clinical oncology (20.05.2010)
Get full text
Journal Article
257 UPDATED DATA FROM A PHASE 3 TRIAL OF EVEROLIMUS (RAD001) VERSUS PLACEBO IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
Kay, A, Motzer, R.J, Figlin, R.A, Escudier, B, Oudard, S, Porta, C, Hutson, T.E, Bracarda, S, Hollaender, N, Urbanowitz, G, Ravaud, A
Published in European urology supplements : official journal of the European Association of Urology (01.03.2009)
Published in European urology supplements : official journal of the European Association of Urology (01.03.2009)
Get full text
Journal Article
Patient-reported outcomes in a randomized trial of everolimus with metastatic renal cell carcinoma patients
Beaumont, J., Cella, D., Hutson, T., Bracarda, S., Grünwald, V., Thompson, J., Ravaud, A., Urbanowitz, G., Hollaender, N., Motzer, R.
Published in Journal of clinical oncology (20.05.2009)
Published in Journal of clinical oncology (20.05.2009)
Get full text
Journal Article
RAD001 vs placebo in patients with metastatic renal cell carcinoma (RCC)after progression on VEGFr-TKI therapy: Results from a randomized, double-blind, multicenter Phase-III study
Motzer, R. J., Escudier, B., Oudard, S., Porta, C., Hutson, T. E., Bracarda, S., Hollaender, N., Urbanowitz, G., Kay, A., Ravaud, A.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
A phase I-II study of everolimus (RAD001) in combination with imatinib in patients (pts) with imatinib-resistant gastrointestinal stromal tumors (GIST)
Dumez, H., Reichard, P., Blay, J. Y., Schöffski, P., Morgan, J. A., Ray-Coquard, I. L., Hollaender, N., Jappe, A., Demetri, G. D.
Published in Journal of clinical oncology (20.05.2008)
Published in Journal of clinical oncology (20.05.2008)
Get full text
Journal Article
Decreased blood platelet volume and count in patients with liver disease
Jørgensen, B, Fischer, E, Ingeberg, S, Hollaender, N, Ring-Larsen, H, Henriksen, J H
Published in Scandinavian journal of gastroenterology (01.06.1984)
Published in Scandinavian journal of gastroenterology (01.06.1984)
Get more information
Journal Article